Literature DB >> 28258301

[Minimally invasive diagnostics and therapy of congenital nasolacrimal duct obstruction].

J Heichel1, H-G Struck2.   

Abstract

BACKGROUND: One of the most frequent issues in pediatric ophthalmology concerns congenital nasolacrimal duct obstruction (CNLDO). Typically, irritation of the medial eyelid angle occurs during the first days of life and later increased epiphora appears as tear production is still reduced in young infants. In the case of intrasaccal or postsaccal nasolacrimal duct stenosis, a chronic dacryocystitis develops.
METHODS: Modern minimally invasive diagnostics and therapy of CNLDO are reviewed by means of a search of the recent literature and reflection of own experiences.
RESULTS: An early diagnosis of CNLDO is desirable. If conservative therapeutic approaches fail, invasive procedures have to be considered. Probing and high pressure syringing of the nasolacrimal ducts remains the therapy of choice. Further therapy options, such as balloon dacryoplasty and dacryoendoscopy are also available. Additionally, due to improvement of the surgical techniques a minimally invasive approach is possible even for dacryocystorhinostomy; nevertheless, this procedure should be considered only as a last resort.
CONCLUSION: Precise classification of CNLDO and knowledge about the possible treatment options are important. Lacrimal surgery in childhood is dominated by transcanalicular procedures. Advanced minimally invasive techniques, such as dacryoendoscopy or modern autostable intubation sets have to be emphasized. All therapeutic interventions can be summarized using a staged therapeutic concept, which should be used individually and patient-centered.

Entities:  

Keywords:  Dacryoendoscopy; Dacryostenosis; Lacrimal duct intubation; Lacrimal duct syringing; Pediatric ophthalmology

Mesh:

Year:  2017        PMID: 28258301     DOI: 10.1007/s00347-017-0472-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  57 in total

1.  Balloon dilatation for treatment of congenital nasolacrimal duct obstruction.

Authors:  D Yüksel; K Ceylan; O Erden; R Kiliç; S Duman
Journal:  Eur J Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 2.597

2.  Hydrostatic pressure as an office procedure for congenital nasolacrimal duct obstruction.

Authors:  Chaim Stolovitch; Adi Michaeli
Journal:  J AAPOS       Date:  2006-06       Impact factor: 1.220

Review 3.  Managing congenital lacrimal obstruction in general practice.

Authors:  J D Young; C J MacEwen
Journal:  BMJ       Date:  1997-08-02

4.  [Treatment of congenital lacrimal duct obstruction: A prospective clinical cohort study].

Authors:  J Heichel; F Bachner; A Schmidt-Pokrzywniak; H-G Struck; U Stuhlträger; T Bredehorn-Mayr
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

5.  A comparison between monocanalicular and pushed monocanalicular silicone intubation in the treatment of congenital nasolacrimal duct obstruction.

Authors:  Dima Andalib; Hossein Mansoori
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

6.  The endoscopic approach for congenital nasolacrimal duct obstruction.

Authors:  K Ingels; P Kestelyn; F Meire; G Ingels; R Van Weissenbruch
Journal:  Clin Otolaryngol Allied Sci       Date:  1997-04

7.  Comparison of monocanalicular stenting and balloon dacryoplasty in secondary treatment of congenital nasolacrimal duct obstruction after failed primary probing.

Authors:  Scott M Goldstein; Jeffrey B Goldstein; James A Katowitz
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-09       Impact factor: 1.746

Review 8.  Management of congenital nasolacrimal duct obstruction.

Authors:  Yasuhiro Takahashi; Hirohiko Kakizaki; Weng O Chan; Dinesh Selva
Journal:  Acta Ophthalmol       Date:  2009-07-21       Impact factor: 3.761

9.  Conservative management of congenital nasolacrimal duct obstruction.

Authors:  P Nucci; C Capoferri; R Alfarano; R Brancato
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1989 Jan-Feb       Impact factor: 1.402

10.  The fluorescein disappearance test (FDT): an evaluation of its use in infants.

Authors:  C J MacEwen; J D Young
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1991 Nov-Dec       Impact factor: 1.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.